labelling

Patients

Strengthening safety: The critical role of reliable labellin...

Learn more about the important role that labelling plays within pharmaceutical labelling and across blood transfusions.

Market Access

The Windsor Framework: Insights on the regulatory shift for ...

The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the pharmaceutical sector

News

'UK Only' red stamp on manufacturing facility

Deadline looms for post-Brexit label changes for UK meds

The MHRA has reminded pharma companies that from 1st January all medicines sold in the UK will have to comply with new labelling requirements.

News

Study finds low secondary cancer risk with CAR-Ts

There’s no doubt that CAR-T therapies have transformed the treatment of many blood cancers, but a risk of secondary malignancies has cast a pall over the class.

Oncology

Warning signs for CAR-T after secondary cancer cases

CAR-T treatments emerged as a major success for the pharma industry when first approved in 2017, but this has been muddied by concerns over secondary malignancies.

Partner Content

Strengthening safety: The critical role of reliable labellin...

The Windsor Framework: Insights on the regulatory shift for ...

Deadline looms for post-Brexit label changes for UK meds

Study finds low secondary cancer risk with CAR-Ts

Warning signs for CAR-T after secondary cancer cases

PRISYM ID Achieves Zebra Technologies Validation

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

labelling

Editor's Picks